HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.

Abstract
N'-aryl acyl hydrazides were identified as P2X7 receptor antagonists. Structure-activity relationship (SAR) studies evaluated functional activity by monitoring calcium flux inhibition in cell lines expressing recombinant human and rat P2X7 receptors. Selected analogs were assayed in vitro for their capacity to inhibit release of cytokine IL-1beta. Compounds with potent antagonist function were evaluated in vivo using the zymosan-induced peritonitis model. A representative compound effectively attenuated mechanical allodynia in a rat model of neuropathic pain.
AuthorsDerek W Nelson, Kathy Sarris, Douglas M Kalvin, Marian T Namovic, George Grayson, Diana L Donnelly-Roberts, Richard Harris, Prisca Honore, Michael F Jarvis, Connie R Faltynek, William A Carroll
JournalJournal of medicinal chemistry (J Med Chem) Vol. 51 Issue 10 Pg. 3030-4 (May 22 2008) ISSN: 0022-2623 [Print] United States
PMID18438986 (Publication Type: Journal Article)
Chemical References
  • Analgesics
  • Hydrazines
  • Interleukin-1beta
  • Isoquinolines
  • P2RX7 protein, human
  • P2rx7 protein, rat
  • Purinergic P2 Receptor Antagonists
  • Quinolines
  • Receptors, Purinergic P2X7
  • Recombinant Proteins
  • Calcium
Topics
  • Analgesics (chemical synthesis, chemistry, pharmacology)
  • Animals
  • Calcium (metabolism)
  • Cell Line
  • Humans
  • Hydrazines (chemical synthesis, chemistry, pharmacology)
  • Interleukin-1beta (antagonists & inhibitors, metabolism)
  • Isoquinolines (chemical synthesis, chemistry, pharmacology)
  • Pain (drug therapy)
  • Pain Measurement
  • Peripheral Nervous System Diseases (drug therapy)
  • Peritoneal Cavity
  • Peritonitis (metabolism, prevention & control)
  • Purinergic P2 Receptor Antagonists
  • Quinolines (chemical synthesis, chemistry, pharmacology)
  • Rats
  • Receptors, Purinergic P2X7
  • Recombinant Proteins (antagonists & inhibitors)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: